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Abstract 
Three distinct ribosome-inactivating proteins (RIPS) were isolated from pokeweed (Phytolacca americana). We identified and sequenced for the 
first time a complete cDNA encoding the pokeweed antiviral protein II (PAP II), which is expressed in the late summer leaves of pokewecd. The 
cDNA of PAP II consists of 1,187 nucleotides and encodes a mature protein of 285 amino acids. Its predicted amino acid sequence isonly 33% similar 
to PAP and PAP-S. The NH2 terminal extrapeptide (25 amino acid residues) was similar but not identical to that of PAP’s extrapeptide. The cDNA 
of PAP II was expressed in E. coli. The growth of the transformants was strongly inhibited after induction of the gene. Furthermore, PAP II, which 
was produced in E. coli, inhibited protein synthesis in a rabbit reticulocyte translation system. Thus, recombinant PAP II would appear to be as 
functional as native PAP in inhibiting protein synthesis in both prokaryotes and eukaryotes. 
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1. Introduction 
The plant pokeweed (Phytolacca americana) produces 
at least three ribosome-inactivating proteins (RIPS) in 
different tissues and at various stages of its development. 
PAP, PAP II and PAP-S are the forms of pokeweed 
antiviral proteins (PAPS) that appear in spring leaves, 
summer leaves and seeds respectively [l-3]. Whereas 
PAP is expressed at all stages of development, PAP II is 
synthetized progressively with the ageing of the plant [4]. 
PAP II does not react with anti PAP serum, whereas 
PAP-S shows a partial reaction [1,3]. 
PAPS inhibit protein synthesis by cleaving the N-gly- 
cosidic bond at adenine 4324 of rat liver 28S-rRNA and 
prevent binding of elongation factors [5,6]. Their antivi- 
ral effect is not understood in molecular terms [7,8]. 
However, it has been suggested that PAP entry is medi- 
ated by changes in the cellular membrane induced by the 
adsorption of viral particles on the cell surface [7]. In this 
process, virus entry is not required. A change in the cell 
membrane integrity could lead to the entry of PAP and 
thus would provide a mechanism of cellular suicide. 
Because of this dual inhibitory activity, PAPS (as other 
RIPS) have become the subject of a wide range of inves- 
tigations concerning their potential application as novel 
therapeutic agents and as putative protective proteins 
used by plants as a defense against viruses [9,10]. 
Recently, studies have demonstrated the use of PAP 
as the killing component of immunotoxins for the treat- 
ment of acute lymphoblastic leukemia [l l-131. An im- 
munotoxin composed of PAP and B43 anti-CD19 mono- 
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clonal antibody with antileukemic efficiency has been 
extensively characterized and approved for a phase I 
clinical trial [12,13]. 
PAP, as a single chain RIP, has some advantages when 
compared with double chain RIP (i.e. ricin). It is smaller 
in size, extremely thermostable and has very low aspeci- 
fit toxicity for intact eukaryotic cells, due to the lack of 
a galactose binding unit. 
Recently, the nucleic acid sequence of PAP [ 141, PAPol 
[15], a sequence related to PAP and the amino acid se- 
quence of PAP-S [16] were determined. However, the 
sequence of PAP II is not known. An amino acid se- 
quence comparison between PAP and PAP-S revealed 
76% homology. It is known from N-terminus protein 
sequencing that PAP II is less homologous [17]. 
Since it has been shown that isozyme forms of various 
RIPS [18] may have different properties that may make 
one form more valuable than another for therapeutic 
applications, it was decided to clone and sequence the 
cDNA encoding the PAP II protein. 
In this analysis RNA was extracted from pokeweed 
leaves of the late summer months and a cDNA library 
was constructed. A complete cDNA encoding PAP II 
was identified, sequenced and expressed in E. coli. Fi- 
nally, the functional efficiency of PAP II to inhibit in 
vitro protein synthesis was demonstrated. 
2. Materials and methods 
2.1. Isolation of PAP-II cDNA 
Total RNA was extracted from the leaves of Phytolacca americano 
in late summer according to the method of Cashmore [19]. Poly (A)’ 
RNA were puriiied on oligo-dT column (Pharmacia). Subsequently, a 
cDNA library was constructed using the ‘Timesaver cDNA Synthesis 
Kit’ from Pharmacia and pUC18 as cloning vector. In order to screen 
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this cDNA library a DNA-fragment of PAP II was amplified by re- 
versed transcriptase PCR (RT-PCR). It was postulated that a highly 
conserved region existed in PAP II found in all RIPS and involved in 
the catalytic action of these proteins [9]. The corresponding degenerated 
nucleid acid sequence to amino acid sequence was designed, primer 
P9 (5’~CGGGATCCCAT(G,A)TA(C,T)TT(G,A)AATCTIGCIGC 
(C,T)T-3’) with a BarnHI site . Five mg of RNA were hybridized with 
5 pmol of primer P9, and RNAs were reverse-transcribed in reaction 
volume of 20 ,ul containing 50 mM Tris-HCl, pH 8.3 ,40 mM KCl, 10 
mM DTT, 6 mM MgCl,, 700 mM of each dNTP, 20 U of RNasin and 
30 U of M-MLV reverse transcriptase (Boehringer). The reaction prod- 
ucts were incubated for 1 h at 37°C. A second primer, P8, was designed 
by reference [17] to the amino acid sequence of the N-terminus of 
PAP II (5’-CCATCGATGAA(C,T)AT(C,T,A)GTITT(C,T)GA(C,T) 
GTIGA(G,A)AA-3’) with a CZaI site . Five ~1 of reverse transcription 
reaction mixture were added to 45 pl of 10 mM Tris-HCl, pH 8.8, 50 
mM KCl, 1.5 mM MgCl,, 0.1% Triton X-100, 30 pmol of primer P8 
and P9, 200 mM of each dNTP and 2 units of Taq polymerase 
@omega). The reaction was performed through 30 cycles of 30 s at 
95”C, 1 min at 54’C and 1 rnin at 72°C. A 500 bp fragment was 
amplilkd, gel purifled and cloned into the pBluescript KS+ vector 
(Stratagene) digested by the appropriate enzymes. The nucleotide se- 
quence was determined using the ‘T7 Sequencing Kit’ (Pharmacia). 
After contirmation of its sequence the fragment was used as a probe 
to screen the cDNA library. The largest positive cDNA clone was 
sequenced in both directions using internal primers. Protein alignments 
were performed using the CLUSTAL program [20]. 
2.2. Cloning of PAP II into a procaryotic expression vector 
The primer PlO (5’-CAGCTGCAGAACATAGTGTTTGACG‘IT- 
GAG-3’) and the primer Pll (5’~CTGGGATCCCTCGAATTCACC- 
AAGGTTAC-3’) were designed to clone the PAP II cDNA without the 
NH,-extrapeptide into the expression vector pFv90 (a generous gift 
from Dr. M. Little, Deutsches Krebsforchungszentrum Heidelberg). 
The plasmid pFv90 was a derivative of the expression vector pSEX [21]. 
It is inducible by IPTG and contains a procaryotic signal peptide of 26 
amino acid residues allowing the secretion of the recombinant protein 
into the periplasm of the bacteria. 
The complete nucleotide sequence of the PCR reaction products were 
compared with the cDNA clone. 
2.3. Expression of PAP II 
The E. coli strain JM109 was transformed by pFV90 or pUC18 with 
a PAP II insert. The transformants were designated pFv9O/PAP II and 
pUC18/PAP II. pFv9O/PAP II was grown at 37°C in LB medium 
containing ampicillin (50 &ml) to an optical density of 0.4 at 600 mn. 
After induction with 1 mM IPTG, the culture was incubated for an 
additional hour at 37°C. Cells were harvested by centrifugation, resus- 
pended in 30 mM Tris-HCl, pH 8, 20% sucrose, 1 mM EDTA and 
subsequently sonicated. Proteins were separated by 12.5% SDS-poly- 
acrylamide gel electrophoresis. 
2.4. Growth inhibition of bacteria 
A preculture of pFv9O/PAP II or pUC18/PAP II was used to initiate 
a culture in LB medium containing 1 mM IPTG. The OD, of the 
cultures were measured every 20 min. 
2.5. Inhibition of in vitro translation 
The activity of the recombinant PAP II to inhibit protein synthesis 
was measured using a rabbit reticulocyte system (Promega). Brome 
mosaic virus RNA (Boehringer) was used as template. The reactions 
were in 12.5 ~1. 
3. Results and discussion 
3.1. Cloning the coding sequence of PAP II 
Late summer leaves of Phytolucca americana were har- 
vested, mRNA was extracted and the corresponding 
cDNA was synthetized. With the help of two degener- 
ated primers, one for the N-terminus and the second for 
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CTTTTTT~TTTCTTTTTKTGTTCAATTACAAAAGCT~FXGCTGCGCAACAGGGAATGA~ 
H K 
ATGAAGGTGTTAGAAGTAGTTGGGTTGGCAATATCGATATGGCTGATGCTT~~CACCA 
MKVLEVVGLAISIWLMLTPP 
GCTTCTKAAACATAGTGTTTGACGTTGAGAATGCCACACCAGAMCCTACKTAATTTT 
ASSNIVFDVENATPETYSNF 
CTGACTAGTTTGCGAGAAGCTGTGAAAGACAAGAAATTGACATGCCATGGAATGATAATG 
LTSLREAVKDKKLTCHGHIM 
GCCACAACCCWACTGMCAACCCAAGTATGTGTTGTTGGTTGACCTCAAATWGGATCTGGA 
ATTLTEQPKYVLVDLKFGSG 
ACATKACATTAGCAATCAGAAGGGGAAACTTATATTTGGAGGGCTATKTGACATTTAC 
TFTLAIRRGNLYLEGYSDIY 
AATGGAAAATGTCGTTATCGGAKTTCAAGGATKAGAATCCGAT’XCCAAGAGACCGTT 
NGKCRYRIFKDSESDAQETV 
'XCCCCGGGGACAAAAGCAAGCCTGGCACTCAGAATAATATCCCCTATGAAAAGAGTTAC 
CPGDKSKPGTQNNIPYEKSY 
AAAGGGATGGAATCAAAGGGTGGGGCTAGAACTAAATTAGGGTTAGGAAAGATAACACTC 
KGMESKGGARTKLGLGKITL 
AAGAGTCGAATGGGTAAAATCTACGGCAAGGATGCAACGGATCAGAAGCAGTATCAAAAA 
KSRMGKIYGKDATDQKQYQK 
AATGAGGCTGAATTTCTTCTTATAGCCGTTCAAATGGTTACTGAGGCA'RXAGGTTCAAA 
NEAEFLLIAVQHVTEASRFK 
TACAT’XAGAACAAAGTGAAGGCTAAATTTGATGATGCCAAEGGTATCAGCCAGAT’XT 
YIENKVKAKFDDANGYQPDP 
AAAGCTATTTCCCTAGAGAAAAATTGGGACAGTGTTKTAAGGTCATTGCAAAAGTTGGC 
KAISLEKNWDSVSKVIAKVG 
ACCTCCGGn;ATAGTACTGTTACTTTACCTGGAGACCTAACT 
TSGDSTVTLPGDLKDENNKP 
TGGACTACGGCCACCATGACGACCTTAAGAACGAClrTCGTT 
WTTATMNDLKNDIMALLTSV 
ACTTGCAAGGTTAAMGTTCCATGTTCCCTGAAATTA~TCCTATTATTATAGG~T~T 
TCKVKSSMFPEIHSYYYRTS 
ATTAGTAACCTTGGTGAATTCGAGTGATTCAAATCATCATA~AA~T~AAT~AGGAGGCA 
ISNLGEFE- 
AGCAACAAATAGTATATTGTTGCACGGCTCTATGTAKCTTAn;TTGTTTTTATCTTCK 
TTTGGGCTTATAGAATCCAATGTTTTAATTAATTTTCTAAAAAAAAA 
Fig. 1. Nucleotide sequence and the deduced amino acid sequence of 
the PAP II-cDNA clone. The putative signal peptide (25 amino acids) 
is encoded by bases 55-129. Bases 13&984 encode a mature protein of 
285 amino acids. The putative polyadelylation signal starts at base 
1,134 and the poly(A) tail starts at base 1,179. 
a highly conserved sequence found in all RIPS and lo- 
cated approximately in the middle of the PAP II protein, 
one fragment was amplified corresponding to the NH, 
terminal part of the protein. This 500 bp fragment was 
used to screen a cDNA library. Several clones were iden- 
tified, the largest one was sequenced. The complete se- 
quence of PAP II is shown in Fig. 1. 
The PAP II cDNA clone was 1,187 bp in length with 
an open reading frame of 932 bp. The deduced polypep- 
tide had a putative signal peptide of 25 amino acid resi- 
dues and a coding sequence of 285 amino acid residues. 
According to the sequence, the theoretical molecular 
weight of PAP II was 32 kDa. The first 30 amino acid 
residues from the deduced mature protein were identical 
to those obtained by amino-terminal sequencing of puri- 
fied PAP II [17] which confirmed that the cDNA clone 
encoded the PAP II polypeptide. As in most plant and 
animal mRNAs, a consensus polyadenylation signal 
(AATAAA) was found 38 bases upstream of a putative 
polyadenylation site. 
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MKMKVLEWGLAISIWLMLTPPAS-S 
MKMSMLVV---TISIVLILAPTSTDA 
***_** * .*** *.*.*... . 
PAP II --NIVFDVENATPETYSNFLTSLREAVKDKKLTCHGMIMATTLTEQPKYV 48 
PAP I VNTIIYNVGSTTISKYATFLNDLRNEAKDPSLKCYGIPMLPNTNTNPKYV 50 
PAP-S INTITFDAGNATINKYATFMESLRNEAKDPSLKCYGIPMLPNTNSTIKYL 50 
.*.......* ..*..*...**...** .*.*.*. l . . . . **. 
PAP II LVDLKFGS-GTETLAIRRGNLYLEGYSDIYNG-KCRYRIFKDS~S----D 92 
PAP I LVELQGSNKKTITLMLRRNNLYVMGYSDPFETNKCRYHIFNDISGTERQD 100 
PAP-S LVKLQGASLKTITLMLRRNNLYVMGYSDPYD-NKCRYHIFNDIKGTEYSD 99 
**_** . . *.** ***_***_ **** . . ****_**** . . * 
PAP II AQETVCPGDKSKPGTQNNIPYEKSYKGM!?SKGG--ARTKLGLGKITLKSR 140 
PAP I VETTLCPNANSRVS--KNINFDSRYPTLESKAGVKSRSQVQLGIQILDSN 148 
PAP-S VENTLCPSSNPRVA--KPIMYNGLYPTLEKKAGVTSRNEVQLGIQILSSD 147 
. ..*.** * * . . . . . . . . . ..*.*.* .*... ** .*.* 
PAP II MGKIYGKDATDQKQYQKNEAEFLLI VENKVKAKFDDA 190 
PAP I IGKISGVMSFTEKT----EAEFLLV AIOMVSEAARFKYIENQVKTNNFN-- 192 
PAP-S IGKISGQGSFTEKI----EAKFLLV -ENQVKTNFN-- 191 
.*** * . ..* **.***.*.***.**.****~~~.~~..~_ 
PAP II NGYQPDPKAISLEKNWDSVSKVIAKVGTSGDSTVTLPGDLKDENNKPWTT 240 
PAP I RAFNPNPKVLNLQETWGKISTAIHD---AKNGVLPKPLELVDASGAKWIV 239 
PAP-S RDFSPNDKVLDLEENWGKISTAIHN---SKNGALPKPLELKNADGTKWIV 238 
*. *...*...*...*..* . * . . . . . . . . . .* . . . . *.. 
PAP II ATMNDLKNDIMALLTHV--TCKV---KSSMFPEIM--SYY-YRTSISNLG 282 
PAP I LRVDEIKPDV-ALLNYVGGSCQTTYYQNAMFPQLIMSTYYNYMVNLGDLF 288 
PAP-S LRVDEIKPDV_GLLNYVNGTCQAT_____________-___-________ 261 
. ...* *. .**..* .*.. 
PAP II EFE 285 
PAP I EGF 291 
PAP-S --- 261 
Fig. 2. Alignment of PAP II, PAP and PAP-S. Primary sequences are aligned to show maximum homologies. Identity (*) and similarity (.) are 
indicated. The conserved region is underlined. 
3.2. Sequence comparison 
Alignment of the amino acid sequences with known 
PAP-sequences revealed several interesting features (Fig. 
2). PAP II was only 33% homologous to PAP and PAP- 
S. In contrast, PAP-S had 76% similarity to PAP indicat- 
ing a higher degree of relatedness and less evolutionary 
diversification among PAP and PAP-S than to PAP II. 
However, PAP II had a similar region at positions 159 
to 184. This relatively well conserved region is thought 
to be the active site of enzymatic activity of the RIPS 
[22,23]. It has been shown for the ricin A-chain that two 
amino acids of these relatively conserved sequences are 
involved in the catalytic activity [22,23]. These amino 
acids correspond to glutamic acid 172 and arginine 175 
of PAP II. 
Besides the catalytic amino acids, some amino acids 
interact with the substrate and others maintain the active 
site in the right conformation. By analogy with the ricin 
A-chain [23], tyrosine 69 and 117 are expected to interact 
with A-4324 of the eukaryotic 28s rRNA. These tyrosine 
residues were also conserved in PAP II. 
The t&dimensional structure of PAP II is not known, 
however, the superposition of the X-ray structures of the 
ricin A-chain and PAP revealed a very similar folding 
pattern with similar positions of key active residues [24]. 
Therefore, it can be thought that the overall structure 
and mechanism of the action of PAP II is similar to that 
of ricin. 
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45 
36 
29 
24 
14,2 
Fig. 3. SDS Polyacrylamide gel electrophoresis of the h’. eoIi proteins. 
Proteins analyzed were from cells without an expression vector (lane 
2), cells containing the expression vector pFvWPAP II and with the 
addition of IPTG (lane 4) or without IPTG (lane 3). The arrow indicates 
the position of the recombinant protein. 
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Fig. 4. Growth curves of transformants. (+) and (-) indicate the pres- 
ence or absence of 1 mM IPTG, respectively. 
The sequence also suggested the presence of extrapep- 
tides at the N- and probably at the C-terminus. The 
signal peptide of PAP II was homologous, but not iden- 
tical to that of PAP’s, documenting an important role of 
this sequence to address PAPS to the cell wall matrix. 
Since the theoretical molecular weight of PAP II is 2 kDa 
higher than the purified form from leaves [3], the cDNA 
may encode a protein harboring a C-terminus. The pre- 
sumed carboxy-extension of PAP II contained the mo- 
tive (MFP) which was also found in PAP and PAP&. 
Comparisons with sequences found in other RIPS show 
no obvious similarities. N-glycosylation sites common to 
other plant proteins that are targeted to vacuoles of the 
plant cell were not observed in PAP II. 
3.3. Expression of PAP II in E. coli 
The cDNA sequence of PAP II was modified in order 
to clone it into the procaryotic expression vector pFv90. 
The promotor of pFv90 gives high expression of foreign 
proteins in E. coli after induction by IPTG. The expres- 
sion vector pFv90/PAP II was introduced into the E. coli 
strain JM109 and the expression of PAP II was induced 
by adding IPTG to the culture medium. 
A protein band at approximately 35 kDa was readily 
detectable on SDS-PAGE after induction with IPTG 
(lane 4, Fig. 3). The recombinant PAP II protein was 
approximately 3 kDa larger in size than the native ma- 
ture PAP II polypeptide, since pFv90 contains a signal 
peptide of 26 amino acid residues which permits the 
secretion of the recombinant protein into the periplasm 
of the bacteria. 
To demonstrate that the cDNA encoding recombinant 
PAP II protein is biologically active two different sets of 
experiments were performed. 
Firstly, the influence of PAP II protein expression on 
E. coli growth was tested. Cultures were initiated from 
overnight precultures and the cell growth was followed 
by measuring the optical density at 600 nm. PAP II 
expression was induced by adding IPTG to the medium. 
As shown in Fig. 4, in the presence of IPTG, bacterial 
culture harboring pFv9OLPAP II stopped growth while 
several control cultures continued to grow. From these 
experiments it can be concluded that the recombinant 
PAP II was active on E. coli ribosomes and inhibited 
protein synthesis in the same way as native PAP and 
MAP (Mirabilis antiviral protein, [26]) do. Single chain 
RIPS can cleave the bond between A-2660 and the ribose 
of the prokaryotic 23SrRNA, a position equivalent to 
the A-4324 of the eucaryotic 28%rRNA [25,27]. There- 
fore single chain RIPS are toxic for E. coli inhibiting 
protein synthesis and leading to growth arrest. 
Secondly, tests were carried out to determine whether 
PAP II inhibits in vitro translation of rabbit reticulocyte 
lysates (Fig. 5). Protein synthesis was obtained with bac- 
terial lysates without plasmid (lane l), with pFvS)O/PAP 
II but without induction (lane 2), and in the presence of 
water (lane 4). However, bacterial lysates containing 
PAP II protein completely inhibited protein synthesis 
(lane 3). These results clearly show the efficiency of re- 
combinant PAP II to inhibit eukaryotic protein synthe- 
sis. 
In recent years, there has been a growing interest in 
using single chain RIPS, such as PAP, as the killing com- 
ponent of immunotoxins [9-131. Frequently one plant 
produces a family of RIPS. The proteins TAP and 
TAP29 from Triochosanthes kirilowi are isozyme forms 
which exhibit different properties making one form more 
1 2 3 4 
Fig. 5. Inhibitory activity of PAP II, on in vitro protein synthesis in a 
rabbit reticulocyte system using Brome mosaic virus RNA as template: 
autoradiography of the in vitro synthetixed proteins analysed by SDS- 
PAGE. Protein syntheses were carried out in the presence of 100 ng of 
proteins of cell lysate from E. coli without an expression vector (lane 
l), with pFv9O/PAP II after induction by IPTG (lane 3), with pFv90/ 
PAP II without IPTG (lane 2) or in the presence of water (lane 4). 
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suitable than another for a certain clinical purpose 1181. 
The potential and ability of PAP II as a therapeutic agent 
is not known, but it can now be used to construct toxic 
hybrid proteins. This may have useful clinical applica- 
tions in the future. 
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